Drug-Resistant Infections : A Threat to Our Economic Future

This report examines the economic and development consequences of antimicrobial resistance(AMR)—the capacity that disease-causing microorganisms acquire to resist the drugs we've createdto fight them. The report uses World Bank Group...

Full description

Bibliographic Details
Main Author:	World Bank
Format:	Report
Language:	English en_US
Published:	World Bank, Washington, DC 2017
Subjects:	ANTIMICROBIALS DRUG-RESISTANT INFECTIONS ANTIMICROBIAL RESISTANCE ECONOMIC IMPACT HEALTHCARE INTERNATIONAL COOPERATION SDGs ANIMAL HEALTH DISEASE CONTROL EPIDEMICS
Online Access:	http://documents.worldbank.org/curated/en/323311493396993758/final-report http://hdl.handle.net/10986/26707

id	okr-10986-26707
recordtype	oai_dc
spelling	okr-10986-267072021-05-25T09:00:08Z Drug-Resistant Infections : A Threat to Our Economic Future World Bank ANTIMICROBIALS DRUG-RESISTANT INFECTIONS ANTIMICROBIAL RESISTANCE ECONOMIC IMPACT HEALTHCARE INTERNATIONAL COOPERATION SDGs ANIMAL HEALTH DISEASE CONTROL EPIDEMICS This report examines the economic and development consequences of antimicrobial resistance(AMR)—the capacity that disease-causing microorganisms acquire to resist the drugs we've createdto fight them. The report uses World Bank Group economic simulation tools to put a price tag onAMR's destructive impacts on the global economy from 2017 through 2050, if adequate measuresaren't taken to contain the AMR threat. The report highlights actions low- and middle-income countries and their development partners can take to counter AMR, and estimates the investment required. It shows that putting resources into AMR containment now is one of the highest-yield investments countries can make. Antimicrobials are drugs that destroy disease-causing microbes, also called pathogens, such as certain bacteria, viruses, parasites, and fungi. The most familiar and important antimicrobials are antibiotics, which treat bacterial infections. Other antimicrobials combat viral and parasitic diseases, such as AIDS and malaria. Since their use began some 70 years ago, antimicrobials have saved hundreds of millions of lives. 2017-05-22T21:13:16Z 2017-05-22T21:13:16Z 2017-03 Report http://documents.worldbank.org/curated/en/323311493396993758/final-report http://hdl.handle.net/10986/26707 English en_US CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo World Bank World Bank, Washington, DC Publications & Research Publications & Research :: Working Paper
repository_type	Digital Repository
institution_category	Foreign Institution
institution	Digital Repositories
building	World Bank Open Knowledge Repository
collection	World Bank
language	English en_US
topic	ANTIMICROBIALS DRUG-RESISTANT INFECTIONS ANTIMICROBIAL RESISTANCE ECONOMIC IMPACT HEALTHCARE INTERNATIONAL COOPERATION SDGs ANIMAL HEALTH DISEASE CONTROL EPIDEMICS
spellingShingle	ANTIMICROBIALS DRUG-RESISTANT INFECTIONS ANTIMICROBIAL RESISTANCE ECONOMIC IMPACT HEALTHCARE INTERNATIONAL COOPERATION SDGs ANIMAL HEALTH DISEASE CONTROL EPIDEMICS World Bank Drug-Resistant Infections : A Threat to Our Economic Future
description	This report examines the economic and development consequences of antimicrobial resistance(AMR)—the capacity that disease-causing microorganisms acquire to resist the drugs we've createdto fight them. The report uses World Bank Group economic simulation tools to put a price tag onAMR's destructive impacts on the global economy from 2017 through 2050, if adequate measuresaren't taken to contain the AMR threat. The report highlights actions low- and middle-income countries and their development partners can take to counter AMR, and estimates the investment required. It shows that putting resources into AMR containment now is one of the highest-yield investments countries can make. Antimicrobials are drugs that destroy disease-causing microbes, also called pathogens, such as certain bacteria, viruses, parasites, and fungi. The most familiar and important antimicrobials are antibiotics, which treat bacterial infections. Other antimicrobials combat viral and parasitic diseases, such as AIDS and malaria. Since their use began some 70 years ago, antimicrobials have saved hundreds of millions of lives.
format	Report
author	World Bank
author_facet	World Bank
author_sort	World Bank
title	Drug-Resistant Infections : A Threat to Our Economic Future
title_short	Drug-Resistant Infections : A Threat to Our Economic Future
title_full	Drug-Resistant Infections : A Threat to Our Economic Future
title_fullStr	Drug-Resistant Infections : A Threat to Our Economic Future
title_full_unstemmed	Drug-Resistant Infections : A Threat to Our Economic Future
title_sort	drug-resistant infections : a threat to our economic future
publisher	World Bank, Washington, DC
publishDate	2017
url	http://documents.worldbank.org/curated/en/323311493396993758/final-report http://hdl.handle.net/10986/26707
_version_	1764462372198547456

Drug-Resistant Infections : A Threat to Our Economic Future

Similar Items